Chaetocin, histone lysine methyltransferase inhibitor (ab144534)

Overview

  • Product name

    Chaetocin, histone lysine methyltransferase inhibitor
  • Description

    Non-selective histone lysine methyltransferase inhibitor
  • Biological description

    Non-selective histone lysine methyltransferase inhibitor (IC50 values are 0.8, 2.5 and 3 μM for Suv39H1, G9a and DIM5 respectively). Competitive, selective thioredoxin substrate. Induces ROS generation and oxidative stress. Selectively induces apoptosis in cancer cell lines. Shows antiproliferative effects in vivo.
  • Purity

    > 98%
  • CAS Number

    28097-03-2
  • Chemical structure

    Chemical Structure

Properties

  • Chemical name

    (3S,3'S,5aR,5aR,10bR,10'bR,11aS,11'aS)-2,2',3,3',5a,5'a,6,6'-Octahydro-3,3'-bis(hydroxymethyl)-2,2'-dimethyl-[10b,10'b(11H,11'H)-bi3,11a-epidithio-11aH-pyrazino[1',2':1,5]pyrrolo[2,3-b]indole]-1,1',4,4'-tetrone
  • Molecular weight

    696.83
  • Molecular formula

    C30H28N6O6S4
  • PubChem identifier

    161591
  • Storage instructions

    Store at -20°C. Store under desiccating conditions. The product can be stored for up to 12 months.
  • Solubility overview

    Soluble in DMSO to 10 mM
  • Handling

    Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

    Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.

  • SMILES

    CN1C(=O)C23CC4(C(N2C(=O)C1(SS3)CO)NC5=CC=CC=C54)C67CC89C(=O)N(C(C(=O)N8C6NC1=CC=CC=C71)(SS9)CO)C
  • Source

    Synthetic

References

This product has been referenced in:

  • Dixit D  et al. Chaetocin-induced ROS-mediated apoptosis involves ATM-YAP1 axis and JNK-dependent inhibition of glucose metabolism. Cell Death Dis 5:e1212 (2014). Read more (PubMed: 24810048) »
  • Chiba T  et al. Histone lysine methyltransferase SUV39H1 is a potent target for epigenetic therapy of hepatocellular carcinoma. Int J Cancer : (2014). Read more (PubMed: 24844570) »
  • Bernhard W  et al. The Suv39H1 methyltransferase inhibitor chaetocin causes induction of integrated HIV-1 without producing a T cell response. FEBS Lett 585:3549-54 (2011). Read more (PubMed: 22020221) »

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab144534.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES, NOT FOR USE IN HUMANS"
For licensing inquiries, please contact partnerships@abcam.com

Sign up